HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Sirtuin 6 ameliorates arthritis through modulating cyclic AMP-responsive element binding protein/CCN1/cyclooxygenase 2 pathway in osteoblasts.

AbstractINTRODUCTION:
CCN1 is an immediate-early gene product pivotal for arthritis progression. We have previously shown that sirtuin 6 (SIRT6) inhibited hypoxia-induced CCN1 expression in osteoblasts. Herein we examined the contribution of cyclic AMP-responsive element binding protein (CREB)/CRE to this suppressive action and the influence of CCN1 on cyclooxygenase (COX) 2 synthesis.
MATERIALS AND METHODS:
MC3T3-E1 murine osteoblasts were cultured under normoxia (21% oxygen) or hypoxia (2% oxygen). Expressions of CCN1, phospho-CREB (Ser133), COX2 and relevant kinases were assessed by Western blot. SIRT6 was overexpressed in cultured osteoblasts and arthritic joints by a lentiviral-based technique. Activities of CCN1 gene promoter constructs were examined by luciferase reporter assay. Interaction between CREB and CCN1 promoter was assessed by chromatin immunoprecipitation (ChIP). Collagen-induced arthritis (CIA) was established in 20 rats to evaluate the effects of SIRT6 therapy on osteoblastic expressions of phospho-CREB, CCN1 and COX2.
RESULTS:
SIRT6 suppressed hypoxia-enhanced CCN1 expression and CREB phosphorylation. Attenuation of calcium/calmodulin-dependent protein kinase II (CaMKII) may be responsible for SIRT6-induced CREB inhibition. CRE at - 286 bp upstream of the ATG start codon was essential for CCN1 expression under hypoxia and SIRT6 reduced hypoxia-stimulated CREB/CRE interaction. Forced expression of CREB rescued SIRT6-suppressed CCN1 synthesis. CCN1 induced COX2 expression in osteoblasts. In rat CIA, the therapeutic effect of SIRT6 was accompanied by decreases in osteoblastic expressions of phospho-CREB, CCN1 and COX2.
CONCLUSION:
Our study indicated that the benefits of SIRT6 to inflammatory arthritis and bone resorption are at least partially derived from its modulation of CREB/CCN1/COX2 pathway in osteoblasts.
AuthorsSze-Kwan Lin, Han-Wei Wang, Chia-Tung Shun, Cheng-Ning Yang, Chi-Yuan Hong, Eddie Hsiang-Hua Lai, Shih-Jung Cheng, Mu-Hsiung Chen, Hsiang Yang, Hung-Ying Lin, Fang-Yu Wu, Sang-Heng Kok
JournalJournal of bone and mineral metabolism (J Bone Miner Metab) Vol. 41 Issue 6 Pg. 772-784 (Nov 2023) ISSN: 1435-5604 [Electronic] Japan
PMID37898986 (Publication Type: Journal Article)
Copyright© 2023. The Japanese Society Bone and Mineral Research.
Chemical References
  • Cyclooxygenase 2
  • Cyclic AMP Response Element-Binding Protein
  • Oxygen
  • Sirtuins
  • Cyclic AMP
Topics
  • Rats
  • Mice
  • Animals
  • Cyclooxygenase 2 (genetics, metabolism, pharmacology)
  • Osteoblasts (metabolism)
  • Cyclic AMP Response Element-Binding Protein (metabolism, pharmacology)
  • Hypoxia
  • Arthritis, Experimental (genetics, metabolism)
  • Phosphorylation
  • Oxygen (metabolism, pharmacology)
  • Sirtuins (metabolism, pharmacology)
  • Cyclic AMP (metabolism, pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: